Abstract
Cannabinoid CB1 receptors (CB1Rs) are the most widespread G-protein-coupled receptors (GPCRs) in the mammalian CNS. CB1Rs are present on inhibitory and excitatory presynaptic terminals supplying Purkinje cells (PCs), the sole output of the cerebellar cortex, where CB1R activation suppresses transmitter release. CB1Rs are part of the endocannabinoid (eCB) system, activated by the lipid mediator 2-arachidonoyl glycerol (2-AG) via retrograde transmission within the cerebellum. CB1Rs also mediate synaptic plasticities to modulate cerebellar learning. This review will discuss the latest knowledge regarding CB1R circuitry and signalling and their potential modulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baillie GL, Horswill JG, Anavi-Goffer S et al (2013) CB1 receptor allosteric modulators display both agonist and signaling pathway specificity. Mol Pharmacol 83:322–338
Brown SP, Safo PK, Regehr WG (2004) Endocannabinoids inhibit transmission at granule cell to Purkinje cell synapses by modulating three types of presynaptic calcium channels. J Neurosci 24:5623–5631
Guo J, Ikeda SR (2004) Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol Pharmacol 65:665–674
Hill AJ, Williams CM, Whalley BJ, Stephens GJ (2012) Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther 133:79–97
Hoffman AF, Lupica CR (2013) Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system. Cold Spring Harb Perspect Med 3 pii: a012237.
Kano M, Ohno-Shosaku T, Hashimotodani Y et al (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89:309–380
Kawamura Y, Fukaya M, Maejima T et al (2006) CB1 is the major cannabinoid receptor at excitatory presynaptic site in the hippocampus and cerebellum. J Neurosci 26:2991–3001
Kishimoto Y, Kano M (2006) Endogenous cannabinoid signaling through the CB1 receptor is essential for cerebellum-dependent discrete motor learning. J Neurosci 26:8829–8837
Kreitzer AC, Regehr WG (2001) Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 21:RC174
Kreitzer AC, Carter AG, Regehr WG (2002) Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34:787–796
Ma YL, Weston SE, Whalley BJ, Stephens GJ (2008) The phytocannabinoid Δ9-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum. Br J Pharmacol 154:204–215
Ohno-Shosaku T, Kano M (2014) Endocannabinoid-mediated retrograde modulation of synaptic transmission. Curr Opin Neurobiol 29:1–8
Patel S, Hillard CJ (2001) Cannabinoid CB1 receptor agonists produce cerebellar dysfunction in mice. J Pharmacol Exp Ther 297:629–637
Pertwee RG, Howlett AC, Abood ME et al (2010) International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62:588–631
RodrÃguez-Cueto C, Benito C, Fernández-Ruiz J et al (2014) Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. Br J Pharmacol 171:1472–1489
Ross RA (2007) Allosterism and cannabinoid CB1 receptors: the shape of things to come. Trends Pharmacol Sci 11:567–572
Stephens GJ (2009) G-protein-coupled-receptor-mediated presynaptic inhibition in the cerebellum. Trends Pharmacol Sci 8:421–430
Stephens GJ (2016) Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia? J Physiol [Epub ahead of print Mar 11]
Szabo B, Urbanski MJ, Bisogno T et al (2006) Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol 577:263–280
Takahashi KA, Linden DJ (2000) Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. J Neurophysiol 83:1167–1180
Tanimura A, Uchigashima M, Yamazaki M et al (2012) Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. Proc Natl Acad Sci U S A 109:12195–12200
Urbanski MJ, Kovacs FE, Szabo B (2010) Endocannabinoid-mediated synaptically evoked suppression of GABAergic transmission in the cerebellar cortex. Neuroscience 169:1268–1278
Vogt KE, Canepari M (2010) On the induction of postsynaptic granule cell-Purkinje neuron LTP and LTD. Cerebellum 9:284–290
Wang X, Horswill JG, Whalley BJ, Stephens GJ (2011) Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum. Mol Pharmacol 79:758–767
Wang X, Whalley BJ, Stephens GJ (2013) The du2J mouse model of ataxia and absence epilepsy has deficient cannabinoid CB1 receptor-mediated signalling. J Physiol 591:3919–3933
Yoshida T, Fukaya M, Uchigashima M et al (2006) Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 26:4740–4751
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Stephens, G.J. (2016). Cerebellar Circuits: Biochemistry, Neurotransmitters and Neuromodulators. In: Gruol, D., Koibuchi, N., Manto, M., Molinari, M., Schmahmann, J., Shen, Y. (eds) Essentials of Cerebellum and Cerebellar Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-24551-5_33
Download citation
DOI: https://doi.org/10.1007/978-3-319-24551-5_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24549-2
Online ISBN: 978-3-319-24551-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)